出版:ABI Research(ABIリサーチ) 出版年月:2022年2月
IoT and Supply Chain Visibility in the Pharmaceutical Industry: Ecosystem Assessment
製薬業界におけるIoTとサプライチェーンの可視性:エコシステム評価
Research Analysis | 1Q 2022 | AN-5352
ページ数 | お問合せください。 |
種別 | 英文市場調査報告書(PDF) |
価格 |
ABIリサーチ「製薬業界におけるIoTとサプライチェーンの可視性:エコシステム評価 – IoT and Supply Chain Visibility in the Pharmaceutical Industry: Ecosystem Assessment」は製薬業界におけるIoTとサプライチェーンを調査し、追跡および監視による可視性については分析・解説しています。
Actionable Benefits
- Understand the functioning of the pharmaceutical supply chain and where visibility is being sought.
- Build out product line and strategy better to address the requirements of the pharmaceutical sector.
- Understand the role of different types of hardware and software in meeting different types of requirements, and how these will evolve in the next 5-10 years.
Critical Questions Answered
- What are the main technologies that will drive supply chain visibility in the pharmaceutical industry?
- What types of assets and products are being tracked, and for what reason?
- What are the challenges that are being faced in the pharmaceutical supply chain, and how is visibility helping to solve them?
Research Highlights
- Forecasts of the TAM and SAM of the pharmaceutical supply chain visibility market.
- Mapping and detailed description of pain points and use-cases requiring tracking and visibility in the pharmaceutical supply chain.
- View of geographies, products, and technologies that will drive change in the pharmaceutical supply chain.
Who Should Read This?
- Hardware and software technology leaders and product owners looking to target the pharmaceutical supply chain visibility market and offer end-to-end visibility.
- Pharmaceutical supply chain and digitization leaders looking to understand what future supply chains will require.
当レポートは下記年間契約サービスに属する市場レポートです。
- 【年間サービス】IoT市場のリサーチサービス
IoT Markets Research Service
ABIリサーチの年間サービスは特定市場の最新・詳細情報をPDFレポート、EXCELファイル、ニューズレターなどを一年を通じて契約者へ提供しています。当レポート単体でももちろんご購入いただけますが、年間契約サービスをご利用いただくことで、継続的に市場情報を入手いただくことが可能です。詳細はChosaReport.comまでお気軽にお問い合わせください。
目次
Table of Contents
1. EXECUTIVE SUMMARY
2. THE PHARMACEUTICAL INDUSTRY: MAPPING AND DESCRIPTION
2.1. Overview of Pharmaceutical Supply Chain
2.2. Product Types
2.3. Countries
2.4. Regulatory Environment
3. TRACKING AND MONITORING OPPORTUNITY ASSESSMENT
3.1. Pain Points and Use Cases
3.2. Technology Landscape
3.3. Software Types
3.4. Data Carrier and Hardware Types
3.5. Tracker Device Features
3.6. Changes in Technology Environment
3.7. Asset Visibility: Opportunities and Challenges
3.8. Recommendations
3.9. Market Sizing